Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
203 studies found for:    Panitumumab
Show Display Options
Rank Status Study
1 Completed
Has Results
Panitumumab in Children With Solid Tumors
Condition: Solid Tumors
Intervention: Biological: Panitumumab
2 Recruiting Cabozantinib and Panitumumab to Treat KRAS Wild-Type Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Biological: Panitumumab;   Drug: Cabozantinib
3 Completed
Has Results
Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)
Conditions: Colon Cancer;   Colorectal Cancer;   Gastrointestinal Cancer;   Metastatic Colorectal Cancer;   Rectal Cancer
Interventions: Drug: Panitumumab;   Drug: Ganitumab;   Drug: Rilotumumab;   Drug: Placebo
4 Active, not recruiting Chemoradiation With Gemcitabine in Combination With Panitumumab for Patients With Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: Panitumumab
5 Recruiting Women's Triple-Negative First-Line Study: A Phase II Trial of Panitumumab, Carboplatin and Paclitaxel (PaCT) in Patients With Localized Triple-Negative Breast Cancer (TNBC) With Tumors Predicted Insensitive to Standard Neoadjuvant Chemotherapy
Condition: Breast Cancer
Interventions: Drug: Panitumumab;   Drug: Paclitaxel;   Procedure: Biopsy;   Drug: Carboplatin
6 Terminated
Has Results
Panitumumab and Irinotecan for Malignant Gliomas
Condition: Malignant Glioma of Brain
Interventions: Drug: Irinotecan;   Drug: Panitumumab
7 Completed
Has Results
Study to Evaluate Mechanisms of Acquired Resistance to Panitumumab
Condition: Metastatic Colorectal Cancer
Interventions: Biological: Panitumumab;   Biological: Ganitumab;   Drug: Irinotecan
8 Completed
Has Results
PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study
Condition: Colorectal Cancer
Interventions: Drug: Oxaliplatin Based Chemotherapy;   Drug: Panitumumab;   Drug: Irinotecan Based Chemotherapy;   Drug: Bevacizumab
9 Completed Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer
Conditions: Rectal Cancer;   Colon Cancer
Interventions: Drug: FOLFOX-4;   Drug: AMG 706;   Biological: Panitumumab (Part 1a only);   Drug: FOLFIRI
10 Terminated
Has Results
Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer
Conditions: Lung Cancer;   Pancreatic Cancer;   Esophageal Cancer
Interventions: Drug: AMG 706;   Biological: Panitumumab;   Drug: Gemcitabine;   Drug: Cisplatin
11 Recruiting Maintenance Therapy With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction and Re-induction After Progress for 1st-line Treatment of Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Maintenance Chemotherapy;   Drug: Panitumumab (Within maintenance phase);   Drug: mFOLFOX6 (Within re-induction phase);   Drug: Panitumumab (Within re-induction phase)
12 Active, not recruiting
Has Results
Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer
Conditions: Cancer of Head;   Cancer of Head and Neck;   Cancer of Neck;   Cancer of the Head;   Cancer of the Head and Neck;   Cancer of the Neck;   Head and Neck Cancer;   Head Cancer;   Head Neoplasms;   Head, Neck Neoplasms;   Neck Cancer;   Neck Neoplasms;   Neoplasms, Head;   Neoplasms, Head and Neck;   Neoplasms, Neck;   Neoplasms, Upper Aerodigestive Tract;   UADT Neoplasms;   Upper Aerodigestive Tract Neoplasms
Interventions: Drug: Panitumumab;   Drug: Cisplatin;   Radiation: Radiation Therapy
13 Recruiting Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: panitumumab;   Drug: Randomization to No Panitumumab
14 Unknown  PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine)
Condition: Cholangiocarcinomas
Interventions: Drug: Cisplatin, Gemcitabine, Panitumumab;   Drug: Cisplatin, Gemcitabine
15 Completed
Has Results
Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy
Conditions: Colorectal Cancer;   Metastatic Cancer
Intervention: Biological: Panitumumab
16 Completed
Has Results
Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: Irinotecan;   Biological: Panitumumab;   Drug: 5-Fluorouracil;   Drug: Leucovorin
17 Terminated
Has Results
Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Panitumumab;   Procedure: Surgery;   Procedure: Radiation Therapy
18 Completed
Has Results
PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors
Conditions: Colon Cancer;   Colorectal Cancer;   Rectal Cancer;   Metastatic Colorectal Cancer
Interventions: Drug: Panitumumab;   Drug: Bevacizumab;   Drug: mFOLFOX6
19 Completed Chemoradiation and Panitumumab for Esophageal Cancer
Conditions: Squamous Cell Carcinoma;   Adenocarcinoma;   Esophageal Cancer;   Gastro-esophageal Junction Cancer
Interventions: Drug: Carboplatin;   Drug: Paclitaxel;   Drug: panitumumab;   Radiation: radiotherapy
20 Completed
Has Results
Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: Panitumumab;   Drug: Carboplatin;   Drug: Gemcitabine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years